FDA Plans Names And Suffixes For Biologic Copycats

Cheaper versions of biotechnology drugs in the U.S. will be distinguished from the expensive brand-name medicine they imitate by attaching a suffix to their generic name, the Food and Drug Administration proposed, a plan that may affect how doctors prescribe the treatments.

Hey, check out all the research scientist jobs. Post your resume today!

MORE ON THIS TOPIC